EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Est. Return
35.48%
This Fund
S&P 500
1 Year Est. Return
+35.48%
AUM
$11.9B
AUM Growth
+$1.56B
(+15%)
Holding
951
Top Buys
| 1 | +$72.6M | |
| 2 | +$65.5M | |
| 3 | +$62.5M | |
| 4 |
Meta Platforms (Facebook)
META
|
+$59.4M |
| 5 |
Progressive
PGR
|
+$54.2M |
Top Sells
| 1 | +$60.6M | |
| 2 | +$53M | |
| 3 | +$52.5M | |
| 4 |
Applied Materials
AMAT
|
+$45.3M |
| 5 |
Electronic Arts
EA
|
+$33.2M |
Sector Composition
| 1 | Technology | 33.94% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12% |
| 4 | Communication Services | 10.12% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Global Payments
GPN
$21.4B
| $3.49M | 0.03% |
43,636
+6,380
|
|
||
302
Incyte
INCY
$20.2B
| $3.4M | 0.03% |
34,200
|
|
||
303
Travelers Companies
TRV
$66.7B
| $3.39M | 0.03% |
11,616
-2,133
|
|
||
304
ConocoPhillips
COP
$139B
| $3.39M | 0.03% |
36,575
+5,657
|
|
||
305
Immunovant
IMVT
$5.64B
| $3.29M | 0.03% |
128,500
+76,000
|
|
||
306
General Motors
GM
$71.2B
| $3.26M | 0.03% |
+39,360
|
|
||
307
Match Group
MTCH
$7.46B
| $3.25M | 0.03% |
100,331
+15,425
|
|
||
308
Praxis Precision Medicines
PRAX
$9.34B
| $3.2M | 0.03% |
+10,500
|
|
||
309
Revolution Medicines
RVMD
$19.7B
| $3.17M | 0.03% |
39,400
|
|
||
310
General Dynamics
GD
$96.5B
| $3.11M | 0.03% |
9,236
+7,466
|
|
||
311
TransDigm Group
TDG
$73.6B
| $3.07M | 0.03% |
2,329
+1,865
|
|
||
312
Veralto
VLTO
$24.2B
| $3.02M | 0.03% |
29,727
+7,727
|
|
||
313
ATI
ATI
$22.4B
| $3.01M | 0.03% |
25,780
+18,600
|
|
||
314
Bristol-Myers Squibb
BMY
$127B
| $2.94M | 0.02% |
54,391
-28,226
|
|
||
315
Simon Property Group
SPG
$66.3B
| $2.93M | 0.02% |
15,632
+526
|
|
||
316
CBRE Group
CBRE
$43.6B
| $2.91M | 0.02% |
18,200
-400
|
|
||
317
Leidos
LDOS
$22.1B
| $2.9M | 0.02% |
15,649
+12,350
|
|
||
318
Bath & Body Works
BBWI
$4.66B
| $2.86M | 0.02% |
140,205
-2,379,386
|
|
||
319
Curtiss-Wright
CW
$25.8B
| $2.84M | 0.02% |
5,057
+4,000
|
|
||
320
Arch Capital
ACGL
$36B
| $2.84M | 0.02% |
29,530
+4,302
|
|
||
321
Neurocrine Biosciences
NBIX
$13.3B
| $2.83M | 0.02% |
19,700
-4,100
|
|
||
322
State Street SPDR S&P Biotech ETF
XBI
$8.13B
| $2.82M | 0.02% |
23,130
+22,130
|
|
||
323
CSX Corp
CSX
$79.4B
| $2.78M | 0.02% |
75,733
-1,141
|
|
||
324
McKesson
MCK
$121B
| $2.71M | 0.02% |
3,264
-95
|
|
||
325
Oshkosh
OSK
$10.6B
| $2.69M | 0.02% |
20,951
+16,500
|
|